Viewing Study NCT07036861


Ignite Creation Date: 2025-12-24 @ 11:58 AM
Ignite Modification Date: 2025-12-29 @ 5:49 PM
Study NCT ID: NCT07036861
Status: COMPLETED
Last Update Posted: 2025-06-25
First Post: 2025-06-17
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (NurofenĀ®) 200 mg/5 ml Oral Suspension
Sponsor: Berlin-Chemie AG Menarini Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module